Austin Goodman

02/27/2025

02/21/2025

Iowa’s Medical Cannabis Monopoly: A State-Sanctioned Failure

Iowa’s medical cannabis program is not just restrictive—it’s an unconstitutional, state-sanctioned monopoly that undermines free market principles and denies patients real access to affordable medicine.

MedPharm Iowa, which produces up to 90% of the state’s medical cannabis, is one of only two licensed manufacturers allowed to operate under Iowa’s overregulated system. The state has created a closed-loop cartel, limiting competition, driving up prices, and ensuring that only a select few benefit—at the expense of patients in need.

This isn’t about public health or safety. It’s about economic control and corporate favoritism disguised as regulation. While other states move toward free-market cannabis policies, Iowa continues to suppress competition and maintain a system that prioritizes profits over patient care.

A truly just system wouldn’t criminalize access while granting monopolies to a state-approved few. Iowa’s restrictive framework must fail on its merits—because it has none.

It’s time to call this what it is: government overreach that violates the principles of fairness, accessibility, and free enterprise.

Officials at manufacturing company MedPharm say that being able to sell ma*****na in its flower form would be a win-win for production companies and customers.

02/15/2025